Chikungunya virus vaccine - Najit Technologies
Alternative Names: HydroVax-005 CHIKVLatest Information Update: 06 Nov 2024
At a glance
- Originator Najit Technologies
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Chikungunya virus infections
Most Recent Events
- 01 Nov 2024 Preclinical development in Chikungunya-virus-infections is ongoing in USA (Parenteral) before November 2024
- 01 Nov 2024 Phase-I clinical trials in Chikungunya virus infections (Prevention) in USA (IM) (NCT06669208)
- 28 Apr 2022 No recent reports of development identified for preclinical development in Chikungunya-virus-infections in USA (Parenteral)